A&I Financial Services LLC Takes $750,000 Position in Phibro Animal Health Corporation $PAHC

Key Points

• A&I Financial Services LLC acquired 29,360 shares of Phibro Animal Health Corporation, valued at approximately $750,000, making it the 29th largest holding in their portfolio.
• The company announced a quarterly dividend of $0.12 per share, with an annualized dividend yield of 1.2% and a payout ratio of 40.68%.
• Phibro reported earnings of $0.57 per share for the last quarter, exceeding the consensus estimate of $0.52, and set its FY 2026 guidance at 2.520-2.700 EPS.

A&I Financial Services LLC purchased a new stake in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 29,360 shares of the company's stock, valued at approximately $750,000. Phibro Animal Health makes up 0.4% of A&I Financial Services LLC's holdings, making the stock its 29th largest holding. A&I Financial Services LLC owned 0.07% of Phibro Animal Health at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. National Bank of Canada FI bought a new stake in shares of Phibro Animal Health in the 1st quarter valued at about $30,000. Lazard Asset Management LLC boosted its stake in Phibro Animal Health by 2,739.7% in the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after purchasing an additional 1,589 shares in the last quarter. Curat Global LLC acquired a new stake in Phibro Animal Health in the 1st quarter worth approximately $146,000. Quantbot Technologies LP boosted its stake in Phibro Animal Health by 53.8% in the 1st quarter. Quantbot Technologies LP now owns 7,870 shares of the company's stock worth $168,000 after purchasing an additional 2,754 shares in the last quarter. Finally, Cetera Investment Advisers acquired a new stake in Phibro Animal Health in the 4th quarter worth approximately $204,000. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Stock Performance

Shares of NASDAQ:PAHC traded down $1.46 during trading on Monday, hitting $38.40. 281,913 shares of the stock traded hands, compared to its average volume of 278,023. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46. The company has a market cap of $1.56 billion, a price-to-earnings ratio of 32.54, a P/E/G ratio of 1.18 and a beta of 0.88. The company has a fifty day moving average price of $32.87 and a two-hundred day moving average price of $26.11. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $41.57.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The company reported $0.57 earnings per share for the quarter, beating analysts' consensus estimates of $0.52 by $0.05. The company had revenue of $378.70 million during the quarter, compared to analysts' expectations of $362.24 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. As a group, equities analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be issued a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, September 3rd. This represents a $0.48 dividend on an annualized basis and a yield of 1.3%. Phibro Animal Health's dividend payout ratio is presently 40.68%.

Analysts Set New Price Targets

A number of research firms recently commented on PAHC. Bank of America lifted their target price on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an "underperform" rating in a research note on Friday, August 29th. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $25.00 to $35.00 in a research note on Monday, July 7th. Morgan Stanley set a $34.00 target price on shares of Phibro Animal Health in a research note on Thursday, August 28th. Zacks Research cut shares of Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 28th. Finally, BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Reduce" and an average price target of $28.40.

Insider Transactions at Phibro Animal Health

In other Phibro Animal Health news, CEO Jack Bendheim sold 14,080 shares of the firm's stock in a transaction that occurred on Tuesday, September 9th. The stock was sold at an average price of $40.33, for a total value of $567,846.40. Following the sale, the chief executive officer directly owned 45,400 shares of the company's stock, valued at approximately $1,830,982. This trade represents a 23.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold a total of 24,622 shares of company stock worth $995,893 in the last quarter. Corporate insiders own 50.07% of the company's stock.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.